Growth Metrics

Idexx Laboratories (IDXX) Total Non-Current Liabilities (2016 - 2026)

Idexx Laboratories has reported Total Non-Current Liabilities over the past 17 years, most recently at $596.6 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 5.34% year-over-year to $596.6 million; the TTM value through Dec 2025 reached $596.6 million, down 5.34%, while the annual FY2025 figure was $596.6 million, 5.34% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $596.6 million at Idexx Laboratories, up from $573.7 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $1.0 billion in Q2 2021 and troughed at $573.7 million in Q3 2025.
  • A 5-year average of $831.1 million and a median of $860.4 million in 2023 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: rose 7.65% in 2021 and later dropped 23.95% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $983.6 million in 2021, then fell by 8.28% to $902.2 million in 2022, then fell by 8.69% to $823.8 million in 2023, then fell by 23.5% to $630.2 million in 2024, then decreased by 5.34% to $596.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for IDXX at $596.6 million in Q4 2025, $573.7 million in Q3 2025, and $648.1 million in Q2 2025.